Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Key Points

• Representative Gilbert Ray Cisneros, Jr. sold shares of ICU Medical, Inc. for between $1,001 and $15,000 on May 6th, which was part of a larger pattern of stock trading involving multiple companies.
• ICU Medical's most recent earnings report indicated a quarterly revenue of $599.49 million, exceeding analysts' expectations and showing a 6.7% increase compared to the same quarter last year.
• Insider trading activity at ICU Medical has included significant sales by directors, with insiders offloading over 36,000 shares valued at nearly $4.9 million in the last 90 days.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of ICU Medical, Inc. (NASDAQ:ICUI). In a filing disclosed on June 06th, the Representative disclosed that they had sold between $1,001 and $15,000 in ICU Medical stock on May 6th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of SpringWorks Therapeutics NASDAQ: SWTX on 7/1/2025.
• Purchased $1,001 - $15,000 in shares of AppLovin NASDAQ: APP on 7/1/2025.
• Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 6/30/2025.
• Purchased $1,001 - $15,000 in shares of CoStar Group NASDAQ: CSGP on 6/30/2025.
• Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 6/27/2025.
• Purchased $1,001 - $15,000 in shares of Xiaomi OTCMKTS: XIACF on 6/27/2025.
• Sold $1,001 - $15,000 in shares of ASML NASDAQ: ASML on 6/27/2025.
• Sold $1,001 - $15,000 in shares of Willis Towers Watson Public NASDAQ: WTW on 6/26/2025.
• Sold $1,001 - $15,000 in shares of Boston Scientific NYSE: BSX on 6/26/2025.
• Sold $1,001 - $15,000 in shares of Liberty Media Corporation - Liberty Formula One Series C NASDAQ: FWONK on 6/26/2025.

ICU Medical Stock Up 0.1%

Shares of ICUI opened at $129.19 on Friday. The business's fifty day moving average price is $131.63 and its two-hundred day moving average price is $143.31. The firm has a market capitalization of $3.18 billion, a price-to-earnings ratio of -33.73 and a beta of 0.87. ICU Medical, Inc. has a 52 week low of $117.92 and a 52 week high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.52 and a current ratio of 2.59.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.23 by $0.49. The business had revenue of $599.49 million for the quarter, compared to analysts' expectations of $574.15 million. ICU Medical had a positive return on equity of 6.75% and a negative net margin of 3.87%. The firm's quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.96 earnings per share. On average, analysts predict that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Insider Activity at ICU Medical

In other news, Director David C. Greenberg sold 1,942 shares of the stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $143.66, for a total transaction of $278,987.72. Following the completion of the sale, the director owned 6,760 shares of the company's stock, valued at $971,141.60. This represents a 22.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Elisha W. Finney sold 600 shares of the business's stock in a transaction on Monday, May 19th. The shares were sold at an average price of $138.92, for a total transaction of $83,352.00. Following the completion of the sale, the director directly owned 3,252 shares in the company, valued at $451,767.84. This represents a 15.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 36,097 shares of company stock valued at $4,860,156. Corporate insiders own 1.50% of the company's stock.

Analyst Upgrades and Downgrades

ICUI has been the subject of a number of recent research reports. Raymond James Financial dropped their price target on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a research note on Friday, May 9th. KeyCorp dropped their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. Finally, Wall Street Zen upgraded ICU Medical from a "hold" rating to a "buy" rating in a research report on Sunday, May 18th. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, ICU Medical has an average rating of "Buy" and an average price target of $192.67.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Harvest Fund Management Co. Ltd acquired a new position in ICU Medical in the fourth quarter valued at about $33,000. Quarry LP lifted its holdings in shares of ICU Medical by 764.3% during the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after purchasing an additional 214 shares in the last quarter. Murphy & Mullick Capital Management Corp acquired a new position in shares of ICU Medical in the 4th quarter valued at approximately $52,000. Venturi Wealth Management LLC increased its stake in ICU Medical by 64.0% during the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after purchasing an additional 206 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its stake in ICU Medical by 88.8% during the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock worth $99,000 after purchasing an additional 300 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.